Beyond Rheumatology 2020-04-28T07:36:47+00:00 Paola Granata Open Journal Systems <p><strong>Beyond Rheumatology </strong>is the new official Journal of CReI (Collegio dei Reumatologi Italiani), a scientific society that brings together outpatient care centers and hospitals rheumatologists. The aim of the Journal is to build a platform for high-quality scientific exchange between the different experts in the real life. It will be focused on publishing new discoveries on diagnostic, prognostic, clinical and therapeutic topics about rheumatology and allied conditions.</p> <p><strong>Beyond Rheumatology</strong> is an international, open access, peer-reviewed journal committed to publishing new discoveries on diagnostic, prognostic, clinical and therapeutic topics about rheumatism and allied conditions. <strong>Beyond Rheumatology</strong> aims to build a platform for high-quality scientific exchange between the different specialists largely focused on the real life of patient’s care. The Journal welcomes research works on rheumatic diseases and allied conditions, reporting perspectives and highlighting new directions also addressed to physicians other than rheumatologists for the management of rheumatology diseases and their comorbidities.</p> <p>Indeed, rheumatology is a multidisciplinary branch of medicine concerned with the study of a wide range of disorders that affect joints, muscles, bones, connective tissues, skin, eyes and systemic inflammatory conditions and that can have a significant impact on healthcare systems, being one of the most common causes of disability and work-related absences. In addition, patients with rheumatologic diseases have been found to be at increased risk of developing a variety of comorbid conditions like malignancies, cardiovascular disease, infections, kidney, lung and gastrointestinal diseases, and depression.</p> <p>Therefore, <strong>Beyond Rheumatology</strong> is addressed to a wide array of physicians, rheumatologists, immunologists, orthopedics, endocrinologists, rehabilitation doctor, dermatologist, radiologists, and other clinical specialists working directly for the management of rheumatology diseases and their comorbidities.</p> What did COVID-19 do to the organization of Italian rheumatology? The examples of Luigi Sacco University Hospital and the Local Health district of ATS Sardegna: the two faces of the same coin 2020-04-28T07:36:47+00:00 Piercarlo Sarzi-Puttini Donatella Ventura Marco Antivalle Alessandra Mutti Laura Boccassini Valeria Giorgi Maria Eva Romano Giuliana Maria Concetta La Paglia Anna Manconi Daniela Marotto <p>Leading scientists and influential professional societies have been warning of the dangers of emerging infections and the threat of a global pandemic for years, but nobody imagined that the new decade would open with the most significant global public health challenge of our lives. The emergence and subsequent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surpassed many of our expectations as the evolving global public health and economic crisis continues to change our personal and professional lives. Although the disease started in China in December 2019, as of 27 March 2020 it had rapidly affected more than half a million people in 176 countries, and these numbers are bound to increase further. A significant proportion of adult patients require hospitalization and may develop life-threatening complications whereas children do not usually develop serious disease but they can transmit the virus. This suggests that age and host-specific environmental factors seem to affect the containment and clearance of the virus, as well as inflammation-related tissue and organ damage...</p> 2020-04-28T07:35:08+00:00 Copyright (c) 2020 the Author(s) Injection therapy in hip osteoarthritis: one year in review 2020-04-25T05:17:51+00:00 Mirian De Souza Alessandro Sinelli Orazio De Lucia <p>Hip osteoarthritis affects a substantial and growing number of people worldwide. Its incidence and prevalence are increasing due to ageing and obesity. It is estimated that it affects between 10 and 18% of individuals over 60 years of age and up to 1 in 3 patients over the age of 85 with a substantial proportion of them experiencing persistent pain, loss of function and decline in health-related quality of life. Our work was aimed at updating the latest data on this field. We searched the following terms on PubMed: ‘<em>injection therapy</em>’, ‘<em>osteoarthritis</em>’ and ‘<em>hip</em>’. We limited our search to the period from 1-1-2018 until 22-6-2019 and to the English language. We retrieved 31 works. We decided to divide the works into three groups: hyaluronic acid in hip OA, other therapies in hip OA and emerging radiological techniques to measure the efficacy of injection therapy. So far, in the literature there is no solid evidence that supports the efficacy of intra-articular infiltration therapies in hip osteoarthritis. The international guidelines reflect this lack of solid scientific evidence. We believe that only original works that show high-level evidence can highlight the benefits of these therapies.</p> 2020-04-24T15:08:14+00:00 Copyright (c) 2020 the Author(s)